Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2023-11-16 00:00:00 ET · period of report 2023-10-31 · accession 0001823239-23-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-16 | 2023-10-31 | MRVI | Herde Kevin | CFO | A - Grant | $5.83 | +1,861 | 93.9K | +2% | +$10.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-10-31 | A | A | 1,861 | $5.83 | 93,925 | D | — | — |